sales@angenesci.com
Login | Register
logo
Structures Search
Home Other Building Blocks H-Val-Phe-OH

H-Val-Phe-OH

CAS No.:
3918-92-1
Catalog Number:
AG00366C
Molecular Formula:
C14H20N2O3
Molecular Weight:
264.3202
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
50mg
98%
1 week
United States
$140
- +
100mg
98%
1 week
United States
$182
- +
Product Description
Catalog Number:
AG00366C
Chemical Name:
H-Val-Phe-OH
CAS Number:
3918-92-1
Molecular Formula:
C14H20N2O3
Molecular Weight:
264.3202
MDL Number:
MFCD00020423
IUPAC Name:
(2S)-2-[[(2S)-2-amino-3-methylbutanoyl]amino]-3-phenylpropanoic acid
InChI:
InChI=1S/C14H20N2O3/c1-9(2)12(15)13(17)16-11(14(18)19)8-10-6-4-3-5-7-10/h3-7,9,11-12H,8,15H2,1-2H3,(H,16,17)(H,18,19)/t11-,12-/m0/s1
InChI Key:
GJNDXQBALKCYSZ-RYUDHWBXSA-N
SMILES:
N[C@H](C(=O)N[C@H](C(=O)O)Cc1ccccc1)C(C)C
Properties
Complexity:
312  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
2  
Defined Bond Stereocenter Count:
0
Exact Mass:
264.147g/mol
Formal Charge:
0
Heavy Atom Count:
19  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
3  
Isotope Atom Count:
0
Molecular Weight:
264.325g/mol
Monoisotopic Mass:
264.147g/mol
Rotatable Bond Count:
6  
Topological Polar Surface Area:
92.4A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-2.2  
Literature
Title Journal
Fragmental modeling of hPepT2 and analysis of its binding features by docking studies and pharmacophore mapping. Bioorganic & medicinal chemistry 20110801
Three-dimensional quantitative structure-activity relationship analyses of beta-lactam antibiotics and tripeptides as substrates of the mammalian H+/peptide cotransporter PEPT1. Journal of medicinal chemistry 20050630
1,2-Benzothiazine 1,1-dioxide alpha-ketoamide analogues as potent calpain I inhibitors. Bioorganic & medicinal chemistry letters 20040223
Inhibitors of tripeptidyl peptidase II. 2. Generation of the first novel lead inhibitor of cholecystokinin-8-inactivating peptidase: a strategy for the design of peptidase inhibitors. Journal of medicinal chemistry 20000224
Properties